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 Chronically discharging mastoid cavities can be troublesome and results of 
surgical management is variable 
 Cavity obliteration at the time of revision mastoidectomy in our centre shows 
dry ear rate of 93% (28/30) 
 This is the first study to show improvement in QoL in relation to otological 
symptoms using disease specific questionnaire (COMBI questionnaire) 
 The benefit to general quality of life is comparable with other otological 
procedures. 
 The biggest improvement was noted in improvement of ‘smelly ears’, ‘ear 





The traditional aims of surgery for chronic otitis media have been to eliminate 
pathological tissue to produce a safe and dry ear; to prevent recurrent disease and if 
possible, to restore the normal function of the middle ear e.g. reconstructing the 
hearing mechanisms. In many cases this has primarily been via mastoidectomy.1 
There are well documented pros and cons for both canal wall up (CWU) and 
canal wall down (CWD) mastoidectomies.  CWD mastoidectomies are accepted 
to have lower rates of residual or recurrent choleasteatoma due to the improved 
exposure, however mastoid cavities themselves can be problematic. Recurrent 
disease, otorrhea and the requirement for regular cleaning can be unpleasant, socially 
embarrassing and have an impact on the patient’s working life2. 
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Revision mastoidectomy aims to resolve issues with recurrent cholesteatoma and 
troublesome cavities. Cavity obliteration is a relatively new practice and can be 
performed at primary mastoidectomy or during revision surgery.  There are a 
variety of techniques and graft material available to obliterate mastoid cavities 
including fascial musculo-periosteal flaps, bone chips, bone pate, cartilage and 
hydroxyapatite. Most studies looking at the effectiveness of cavity obliteration use 
objective measurements such as dry ear rate3–9. There have been two studies looking 
at generic quality of life measurements in revision mastoidectomy with cavity 
obliteration. These both showed a good improvement in quality of life demonstrated 
by Glasgow Benefit Inventory (GBI) score in comparison to other general ENT 
procedures10,11. But there are no studies analysing the specific aspects of this 
improvement using disease specific tools. This information would be useful to counsel 
the patients before surgery and to convince the healthcare management about the 
usefulness of these procedures.  
 
The GBI is a validated questionnaire to measure quality of life outcomes 
following an otolaryngological intervention, across three domains – general, 
physical and social12. However, it measures generic outcomes and is not 
specific to a disease process. Recently, Phillips et al validated the Chronic Otitis 
Media Benefit Inventory (COMBI) as a disease-specific patient reported outcome 
measure for chronic otitis media which includes questions relating to hearing, 
otorrhoea, tinnitus and dizziness as well as questions relating to daily activities and 
healthcare requirements13. This questionnaire has 12 questions and benefit is also 
measured from -100 to +100.  
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The aim of this study was to measure the outcomes following revision mastoidectomy 
with cavity obliteration – both objectively in terms of dry ear rates and with regard to 




2.1 Ethical considerations – Prospective audit data from patients undergoing 
surgery was used and were sent anonymised questionnaires with a covering letter. 
There was no obligation for the patients to complete the questionnaires. 
2.2. Study design quantitative data 
 
Patients were identified who had revision mastoidectomy and cavity obliteration 
between 2010-2017. 30 were identified and all were invited to take part. All patients 
had presented to the clinic with troublesome, persistent otorrhea which failed to 
respond to conservative management. Basic demographic data were recorded 
including age and gender. Data regarding comorbidities such as diabetes mellitus 
were recorded. Operative data were recorded including operative side, method of 
access, materials used for obliteration as well as extent of recurrent disease. 
Furthermore, dry ear outcome on clinic review was recorded as well as duration of 
follow-up for all patients. 
2.3 Study design qualitative data 
 
A unique code was assigned to each patient and both GBI and COMBI questionnaires 
sent via post with a stamped address envelope for the patients to return their 
anonymised questionnaires. Returned questionnaires were matched to the unique 
patient code and recorded in Excel. Average benefit across each of the GBI domains 
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was calculated and overall average benefit on the COMBI questionnaire was 
calculated. 
2.4 Surgical technique and follow-up 
 
The operations were performed by the same surgeon by post auricular route. Both 
mucosal disease and cholesteatoma was encountered and the details of the type of 
materials used were recorded. Whether or not an ossiculoplasty was attempted was 
also recorded. The follow-up schedule is at 3 months, 6 months then yearly until 
five years unless the patient wishes to remain under review. Diffusion weighted 




Primary outcome measure was dry ear rate and maximum length of time at which 
dry ear was recorded. The secondary outcome measure was QoL measurement 
using GBI and COMBI questionnaire. Pre and post-operative audiograms were 
recorded, and pure tone averages were calculated as per AAO-HNS guidelines. Air-
bone gaps were also calculated to assess pre-operative and post-operative hearing 
status. Wilcoxon matched-pairs signed rank test was used to assess statistical 
significance between pre-operative and post-operative results. This was performed 
using GraphPad Prism. 
 
Results 
3.1 Patient demographics 
 
The average age of the patients was 39 (age range 15 – 71). 43.3% of participants 
were male; 56.7% were female. The average length of follow-up was 44.7 months 
(range 6 – 90 months). 10 (33.3%) were smokers and one (3.3%) was diabetic 
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showing a low level of co-morbidity. One patient did not wish to participate in the 
questionnaire and thus was excluded from questionnaire analysis. 
 
3.2 Surgical findings and techniques 
Seven patients (24.1%) had mucosal disease intraoperatively. Twenty-three patients 
(79.3%) had recurrent cholesteatoma. Various materials were used for cavity 
obliteration – cartilage in 18 patients (62%), calcium sulphate pellets in 6 patients 
(20.6%), cartilage and bone paste in 3 patients (10.3%) and cartilage and calcium 
sulphate pellets in 2 patients (6.9%). Ossiculoplasty was attempted in eleven patients 
(37.9%). 
 
3.2 Dry ear rates, recurrence and follow-up 
Dry ear was achieved at final follow-up in 27 patients (93.1%). Average length of 
follow-up was 48.8 months (range 6 – 108 months). Four patients were lost to 
follow-up before five years (range 6-48 months).  
 
Two (6.8%) patients experienced discharge at 12 and 24 months respectively 
and follow-up is ongoing. There were no recurrences of cholesteatoma at clinic 
follow-up.  
 
The dry ear rate as a survival curve over 60 months is shown in Figure 1. 
 
3.3. Pure tone averages 
Pre and post-op audiograms were available in 28 patients. The average pre-
operative dbHL for air conduction was 27.34 and the average post-operative 
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dBHL recorded at the first post-operative visit (3 months) was 27.35.  The 
difference between the pre and post-operative bone conduction results was no 
statistically significant (p=0.6571). 
 
The average pre-operative dbHL for air conduction was 52.6 and the average 
post-operative dBHL was 46.33. There was no statistically significant difference 
between the pre and post-operative air conduction results (p=0.1835). 
 
More recently performed audiograms were available in 22 patients which more 
closely coincided with this study. These occurred at an average interval of 49 
months. The average dBHL for bone conduction was 24.125 dbHL. The 
difference between this and the pre-operative bone conduction pure tone 
averages was not statistically significant (p=0.2791). The average dbHL for air 
conduction was 52.6 dbHL. The difference between this and the pre-operative 
air conduction pure tone averages was not statistically significant (p=0.1494). 
 
3.4 Airbone gap 
The average change in airbone gap was 5.94dB at first audiogram. The change 
in air-bone gap was not found to be statistically significant (p=0.4375). (See 
Figure 1). With regards to the audiograms performed later, the average change 
was 3.24dB compared with pre-operatively. This was not found to be statistically 
significant(p=0.9134). 
 
3.5 General QoL  
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Twenty-five patients returned their questionnaires, giving a response rate of 83.3%. In 
the GBI scores, average total benefit for revision mastoidectomy with cavity 
obliteration was +27.2 (95% CI +13.75-+40.2). Benefit by different domains of GBI is 
shown in Table 1. The GBI shows a positive impact on all domains of QoL.  
 
3.6 Disease specific QOL  
With regards to scores in the COMBI questionnaires, the average total benefit was 
+24.5. (95% CI +8.2 - +41.1) A breakdown per question asked is shown in table 1. 
The biggest improvements were relating to otorrhea – ‘ear discharge’, ‘smelly ear’ and 
the ‘need to take eardrops’. 
 
Discussion 
Synopsis of key findings 
The response rate for this study was high. This may signal that patients have a positive 
view of their surgery and our results show an objective improvement in symptoms 
based on reported dry ear rate at clinic follow-up. This is the main symptom that should 
be addressed by performing revision mastoidectomy with cavity obliteration. Quality 
of life is subjective but important as this provides surgeons with a perspective on how 
a procedure can affect a patient. Revision mastoidectomy with cavity obliteration 
shows a good improvement in both GBI and COMBI scores.  
 
With regard to the COMBI questionnaire, patients report that the primary aim of 
surgery is mostly achieved, in that patients report reduced otorrhea and less need for 
topical treatment for their ears. Unsurprisingly, hearing is the only domain which does 
not show an improvement. Although it is ideal to be able to reconstruct the hearing 
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mechanism, the main aims of surgery remain to achieve a safe dry ear and to 
eradicate disease. The possibility of improving hearing also depends on other factors 
such as condition of the ossicular chain and middle ear aeration. In our group of 
patients who had data available, half had a reduction in air-bone gap but this was not 
statistically significant. There was no significant reduction in bone conduction in our 
patients. Clearly, the level of hearing will have an impact on patients as it affects their 
daily social and working lives. 
 
Comparison with other studies 
With reference to the GBI, revision mastoidectomy with cavity obliteration compares 
favourably with a study looking at a variety of tympanomastoid techniques to address 
chronic otitis media14, but scores less well than BAHA  and cochlear implant12,15. The 
GBI average total benefit of +27.2 in this group is comparable to other studies 
looking at GBI in primary and revision cavity obliteration5,6.  
 
The dry ear rate is comparable with other studies looking at canal obliteration 
in either primary or revision mastoidectomy3–9.  
 
Clinical applicability of study 
These results show the benefit of the technique of cavity obliteration in tackling the 
chronically discharging ear after previous mastoid surgery. They may also help the 
consent process in terms of providing a realistic picture of potential outcomes – in that 
a dry ear is certainly achievable but an improvement in hearing is less likely – and thus 
manage patient expectations. 
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